Sign Up to like & get
recommendations!
0
Published in 2017 at "Cancer Immunology, Immunotherapy"
DOI: 10.1007/s00262-017-2073-0
Abstract: Malignant melanoma incidence has been increasing for over 30 years, and despite promising new therapies, metastatic disease remains difficult to treat. We describe preliminary results from a Phase I clinical trial (NCT01586403) of adoptive cell therapy…
read more here.
Keywords:
melanoma;
reactive tcr;
transduced cells;
tcr transduced ... See more keywords